-
Jun, 17 2022 — The May 2022
Medicare Part D plan formulary (or drug list) updates included
59 new drug codes or NDCs representing
44 different medications, including
17 new generics.
The NDC uniquely identifi . . .
-
Jun, 17 2022 — The June 2022 Medicare Part D plan drug list updates include ten (10) newly-introduced
generics and seven (7) newly-introduced brand drugs, including: FLEQSUVY®,
IBSRELA®, LOFENA®, PHEXXI®, PYRUKYND®, SOAANZ®, and ZEGALOGUE®.
-
May, 19 2022 — The May 2022 Medicare Part D plan drug list updates include six (6) newly-introduced generics and five (5) newly-introduced brand drugs, including: CIBINQO®, DARTISLA®, DHIVY®, ELYXYB®, and RECORLEV®.
-
Apr, 19 2022 — The April 2022 Medicare Part D plan drug list updates include five (5) newly-introduced generics and six (6) newly-introduced brand drugs, including: ADBRY®, BYLVAY®, CORTROPHIN®, SKYTROFA®, TARPEYO®, and VOXZOGO®.
-
Mar, 29 2022 — The March 2022 Medicare Part D plan drug list updates include 3 newly-introduced generics and 12 newly-introduced brand drugs, including: BESREMI®, CENTANY®, EPRONTIA®, EXKIVITY®, LIVMARLI®, LIVTENCITY®, OPZELURA®, QULIPTA®, SCEMBLIX®, TICOVAC®, TRUDHESA®, VUITY®
-
Feb, 28 2022 — The February 2022 Medicare Part D plan drug list updates include eight (8) newly-introduced generic drugs - and nine (9) newly-introduced brand-name drugs, including: INVEGA HAFYERA®, LOREEV XR®, LYBALVI®, PENTACEL®, TAVNEOS®, TRUSELTIQ®, TYRVAYA®, WELIREG®, and WINLEVI®
-
Aug, 14 2021 — The August 2021 Medicare Part D plan formulary (or drug list) updates included 39 new drug codes or NDCs representing 25 different medications, including 14 new generics.
The NDC uniquely identifie . . .
-
Aug, 14 2021 — As you may know, Medicare Part D prescription drug plans update their plan formularies (drug lists) throughout the plan year and the August 2021
Medicare Part D formulary updates included 25 new drug . . .
-
Aug, 14 2021 — The August 2021 Medicare Part D plan drug list updates include nine (9) newly-introduced generic drugs - and three (3) newly-introduced brand-name drugs, including: FOTIVDA®, QELBREE®, and THYQUIDITY®.
-
Jun, 25 2021 — The June 2021 Medicare Part D plan drug list updates include five (5) newly-introduced generic drugs - and six (6) newly-introduced brand-name drugs, including: GEMTESA®, IMPAVIDO®, LUCEMYRA®, RELTONE®, UKONIQ®, and ZILXI®.
-
Jun, 25 2021 — As you may know, Medicare Part D prescription drug plans update their plan formularies (drug lists) throughout the plan year and the June 2021
Medicare Part D formulary updates included 29 new drugs, . . .
-
May, 21 2021 — As you may know, Medicare Part D prescription drug plans update their plan formularies (drug lists) throughout the plan year and the May 2021
Medicare Part D formulary updates included 28 new drugs, . . .
-
May, 21 2021 — The May 2021 Medicare Part D plan drug list updates include nine (9) newly-introduced generic drugs - and six (6) newly-introduced brand-name drugs, including: BRONCHITOL®, KLISYRI®, LUPKYNIS®, TEMIXYS®, TEPMETKO®, and VERQUVO®.
-
Apr, 27 2021 — The April 2021 Medicare Part D plan drug list updates include 26 newly-introduced generic drugs - and 11 newly-introduced brand-name drugs, including: Cystadrops®, Hemady®, Impeklo®, Nyvepria®, ONUREG®, ORGOVYX®, ORLADEYO®, SUTAB®, Travatan Z®, and XYWAV®.
-
Apr, 27 2021 — As you may know, Medicare Part D prescription drug plans update their plan formularies (drug lists) throughout the plan year and the April 2021
Medicare Part D formulary updates included 95 new drugs . . .